Jeffrey Robert Ajer, Director at NEKTAR THERAPEUTICS (NKTR), sold 4,198 shares at $3.16 ($13K) on 2022-09-23, disclosed to the SEC on 2022-09-26.
Seasonal sale ($13k) by Director — this insider has traded NKTR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |